Matches in Ubergraph for { <http://purl.obolibrary.org/obo/NCIT_C188903> ?p ?o ?g. }
Showing items 1 to 54 of
54
with 100 items per page.
- NCIT_C188903 IAO_0000115 "A regimen consisting of polatuzumab vedotin, bendamustine and rituximab that may be used in the treatment of diffuse large B-cell lymphoma (DLBCL)." @default.
- NCIT_C188903 NCIT_NHC0 "C188903" @default.
- NCIT_C188903 NCIT_P106 "Therapeutic or Preventive Procedure" @default.
- NCIT_C188903 NCIT_P108 "Pola-BR Regimen" @default.
- NCIT_C188903 NCIT_P208 "CL1794043" @default.
- NCIT_C188903 NCIT_R123 NCIT_C104153 @default.
- NCIT_C188903 NCIT_R123 NCIT_C129821 @default.
- NCIT_C188903 NCIT_R123 NCIT_C129822 @default.
- NCIT_C188903 NCIT_R123 NCIT_C129823 @default.
- NCIT_C188903 NCIT_R123 NCIT_C141215 @default.
- NCIT_C188903 NCIT_R123 NCIT_C1512 @default.
- NCIT_C188903 NCIT_R123 NCIT_C1590 @default.
- NCIT_C188903 NCIT_R123 NCIT_C163758 @default.
- NCIT_C188903 NCIT_R123 NCIT_C164034 @default.
- NCIT_C188903 NCIT_R123 NCIT_C1702 @default.
- NCIT_C188903 NCIT_R123 NCIT_C186664 @default.
- NCIT_C188903 NCIT_R123 NCIT_C1908 @default.
- NCIT_C188903 NCIT_R123 NCIT_C1909 @default.
- NCIT_C188903 NCIT_R123 NCIT_C20401 @default.
- NCIT_C188903 NCIT_R123 NCIT_C2114 @default.
- NCIT_C188903 NCIT_R123 NCIT_C274 @default.
- NCIT_C188903 NCIT_R123 NCIT_C2842 @default.
- NCIT_C188903 NCIT_R123 NCIT_C307 @default.
- NCIT_C188903 NCIT_R123 NCIT_C308 @default.
- NCIT_C188903 NCIT_R123 NCIT_C61565 @default.
- NCIT_C188903 NCIT_R123 NCIT_C697 @default.
- NCIT_C188903 normalizedInformationContent "100" @default.
- NCIT_C188903 referenceCount "1" @default.
- NCIT_C188903 hasExactSynonym "Bendamustine-Polatuzumab Vedotin-Rituximab Regimen" @default.
- NCIT_C188903 hasExactSynonym "Bendamustine-Polatuzumab Vedotin-Rituximab" @default.
- NCIT_C188903 hasExactSynonym "Bendamustine/Polatuzumab Vedotin/Rituximab Regimen" @default.
- NCIT_C188903 hasExactSynonym "Bendamustine/Polatuzumab Vedotin/Rituximab" @default.
- NCIT_C188903 hasExactSynonym "Bendamustine/Polivy/Rituxan Regimen" @default.
- NCIT_C188903 hasExactSynonym "Pola-BR Regimen" @default.
- NCIT_C188903 hasExactSynonym "Polatuzumab Vedotin Plus Bendamustine/Rituximab Regimen" @default.
- NCIT_C188903 hasExactSynonym "Polatuzumab Vedotin-BR Regimen" @default.
- NCIT_C188903 hasExactSynonym "Polatuzumab Vedotin-Bendamustine/Rituximab Regimen" @default.
- NCIT_C188903 inSubset NCIT_C160950 @default.
- NCIT_C188903 inSubset NCIT_C160952 @default.
- NCIT_C188903 type Class @default.
- NCIT_C188903 isDefinedBy ncit.owl @default.
- NCIT_C188903 label "Pola-BR Regimen" @default.
- NCIT_C188903 subClassOf B2fd4d76497079be1d8142e4cd6e56cee @default.
- NCIT_C188903 subClassOf B3e8b7fc8356b6f65343f5b7304b1b633 @default.
- NCIT_C188903 subClassOf B908d99f988c2b3082f57c0928b2c164a @default.
- NCIT_C188903 subClassOf Ba64a4f2a32daeb85b6971cae74256aa2 @default.
- NCIT_C188903 subClassOf Be73990ed9fc436e50589756d9988190f @default.
- NCIT_C188903 subClassOf Bef335d9bb538f964162be02755b0fef6 @default.
- NCIT_C188903 subClassOf NCIT_C12218 @default.
- NCIT_C188903 subClassOf NCIT_C186719 @default.
- NCIT_C188903 subClassOf NCIT_C186724 @default.
- NCIT_C188903 subClassOf NCIT_C188903 @default.
- NCIT_C188903 subClassOf NCIT_C62634 @default.
- NCIT_C188903 subClassOf NCIT_C63442 @default.